A new malaria vaccination tool based on replication-competent Plasmodium falciparum parasites
D Moita, M Prudêncio - EMBO Molecular Medicine, 2024 - embopress.org
Recently licensed subunit vaccines represent the first and, thus far, the only approved
agents for vaccination against malaria. However, these vaccines still fail to confer highly …
agents for vaccination against malaria. However, these vaccines still fail to confer highly …
[HTML][HTML] Bridging the gap to malaria vaccination in Africa: Challenges and opportunities
OJ Okesanya, F Atewologun… - Journal of Medicine …, 2024 - Elsevier
The current state of malaria is devastating owing to the continual dominance of P. falciparum
in the African region. Despite progress, the burden remains high, with the African continent …
in the African region. Despite progress, the burden remains high, with the African continent …
Design and Evaluation of Chimeric Plasmodium falciparum Circumsporozoite Protein-Based Malaria Vaccines
WH Stump, HJ Klingenberg, AC Ott, DM Gonzales… - Vaccines, 2024 - mdpi.com
Efficacy data on two malaria vaccines, RTS, S and R21, targeting Plasmodium falciparum
circumsporozoite protein (Pf CSP), are encouraging. Efficacy may be improved by induction …
circumsporozoite protein (Pf CSP), are encouraging. Efficacy may be improved by induction …